- Inicio
- Proyectos y Estudios
- A RETROSPECTIVE, MULTICENTER AND OBSERVATIONAL STUDY OF OSIMERTINIB MONOTHERAPY TREATMENT IN SUBJECTS WITH ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) EGFR-T790M MUTATION-POSITIVE WHO HAVE RECEIVED THE TREATMENT WITHIN THE SPECIAL USE MEDICA TION PROGRAM (SUMP) IN SPAIN.
A RETROSPECTIVE, MULTICENTER AND OBSERVATIONAL STUDY OF OSIMERTINIB MONOTHERAPY TREATMENT IN SUBJECTS WITH ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) EGFR-T790M MUTATION-POSITIVE WHO HAVE RECEIVED THE TREATMENT WITHIN THE SPECIAL USE MEDICA TION PROGRAM (SUMP) IN SPAIN.
Datos básicos
Objetivos del proyecto
Observaciones: Estado Comité: ACTIVO
Documentos
- No hay documentos
Participantes
Grupos
Financiadores - Promotores
GRUPO ESPAÑOL DE CANCER DE PULMON
Cita
A RETROSPECTIVE, MULTICENTER AND OBSERVATIONAL STUDY OF OSIMERTINIB MONOTHERAPY TREATMENT IN SUBJECTS WITH ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) EGFR-T790M MUTATION-POSITIVE WHO HAVE RECEIVED THE TREATMENT WITHIN THE SPECIAL USE MEDICA TION PROGRAM (SUMP) IN SPAIN. (GEC-OSI-2018-01). GRUPO ESPAÑOL DE CANCER DE PULMON. 2019-2021. IP:ÓSCAR JOSÉ JUAN VIDAL.
Portal de investigación